This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
HBSP (USA)
-
Brighter Smiles for the Masses--Colgate vs. P&G (Spanish version)
Oberholzer-Gee, Felix; Yao, Dennis; Azevedo Jorge, FilipaCase HBS-707S33StrategyIn 2000, Procter & Gamble Co. introduced Crest Whitestrips, a new, revolutionary product that allowed consumers to whiten their teeth at home. With Whitestrips, P&G created an entire new category in oral care, worth $460 million in 2002. Whitestrips sent P&G's main competitor in oral care, Colgate Palmolive Co., scrambling because several patents protected the strips, making it difficult for Colgate to copy the invention. But in September 2002, t...Starting at €8.20
-
Launching Prius (Spanish version)
Reinhardt, Forest L.; Yao, Dennis; Egawa, MasakoCase HBS-712S03StrategyIn 1995, Hiroshi Okuda, president of Toyota Motor Corp., considers whether to push for a more aggressive launch of the Toyota Prius--an automobile that incorporates Toyota's new and technically advanced hybrid power train. This launch decision allows discussion of the importance of the Prius in Toyota's overall product strategy and explores issues ranging from market structure to competitive advantage and competitive dynamics.Starting at €8.20
-
Framework for Risk Management
Froot, Kenneth A.; Scharfstein, David S.; Stein, Jeremy C.Article HBS-94604-EStrategyIn recent years, managers have become aware of how their companies can be buffeted by risks beyond their control. To insulate themselves from such risks, many companies are turning to the derivatives markets, taking advantage of instruments like forwards, futures, options, and swaps. Although heavily involved in risk management, most companies do not have clear goals underlying their hedging programs. Without such goals, using derivatives can be ...Starting at €8.20
-
Oaktree and the Restructuring of CIT Group (B)
Ivashina, Victoria; Scharfstein, David S.Case HBS-214036-EFinanceThis supplement presents the actual terms of the rescue financing provided by a group of private investors to CIT. It is intended to be distributed at the end of the discussion of "Oaktree and the Restructuring of CIT Group (A)" (HBS No. 214-035) and can be used as background to reflect on the students' proposal of financing terms for the $3 billion rescue financing of CIT.Starting at €5.74
-
Momentive Performance Materials, Inc., Teaching Note
Ivashina, Victoria; Scharfstein, David S.Teaching Note HBS-214057-EFinanceTo maximize their effectiveness, color cases should be printed in color. Teaching note for case 210081.Starting at €0.00
-
The Proposed Merger of M&T Bank and Hudson City Bancorp (B)
Scharfstein, David S.Case HBS-216047-EFinanceStarting at €5.74
-
OnDeck Capital, Inc.
Scharfstein, David S.; Begenau, JulianeCase HBS-219100-EFinanceStarting at €8.20
-
Live Oak Bank
Scharfstein, David S.; Williams, Emily; O'Brien, ShawnCase HBS-219103-EFinanceStarting at €8.20
-
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug, Teaching Note
Oberholzer-Gee, Felix; Yao, DennisTeaching Note HBS-707542-EStrategyTeaching note to 706454.Starting at €0.00
-
Brighter Smiles for the Masses--Colgate vs. P&G, Teaching Note
Oberholzer-Gee, Felix; Yao, DennisTeaching Note HBS-707545-EStrategyTeaching note to 706435.Starting at €0.00